CHM-1101

N/A

Report date: 2022/10/31 17:10:05

Base Information

Drug NameCHM-1101
Drug Alias Namechlorotoxin [CLTX]-CAR T cellschlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes NCI SYsCAR-T cells with a chlorotoxin tumor-targeting domainChlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes - City of Hope National Medical Centerchlorotoxin chimeric antigen receptor (CLTX-CAR) T cell therapy - City of Hope National Medical Center +[7] 
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyCell and gene therapy > Gene therapy
Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsProstatic NeoplasmsColorectal NeoplasmsMelanoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical CenterChimeric Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCity Of Hope National Medical CenterChimeric Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic NeoplasmsColorectal NeoplasmsMelanoma +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A